CAPA — Corrective and Preventive Actions — is a systematic approach to investigating and resolving quality issues and preventing their recurrence. It is a core element of any Pharmaceutical Quality System and is routinely scrutinized during regulatory inspections.
What Is the CAPA System?
The CAPA system distinguishes between corrective actions (actions taken to eliminate the cause of a detected non-conformity) and preventive actions (proactive actions to prevent potential issues). CAPAs are triggered by deviations, complaints, audit findings, out-of-specification results, or trend data. Each CAPA must include root cause analysis, action planning, implementation, verification of effectiveness, and closure.
Regulatory Framework
21 CFR Part 820.100 (for medical devices) and ICH Q10 (Section 3.2.2) formally require CAPA systems. EU GMP Chapter 1 mandates corrective and preventive actions as part of the Pharmaceutical Quality System. The FDA considers CAPA effectiveness a key indicator of a facility’s quality culture, and inspectional findings frequently cite inadequate CAPA systems under 21 CFR Part 211.
Key Requirements
Each CAPA must be documented with: a clear description of the problem, root cause analysis results, defined actions with owners and due dates, interim controls to mitigate risk during implementation, and a plan to verify that actions were effective. Effectiveness checks must be objective and measurable — for example, showing that the recurrence rate for a specific deviation type drops to zero over six months.
Practical Implementation
CAPAs are typically managed through a dedicated electronic system that tracks each item through its lifecycle. A CAPA board or quality review committee prioritizes and assigns resources based on risk. Closed CAPAs are periodically trended to identify systemic issues — for example, repeated CAPAs in the same department may indicate a broader training or procedural deficiency.
Common Pitfalls
The most frequent regulatory finding is inadequate effectiveness checks — closing a CAPA when actions are merely implemented, without verifying that the problem is actually resolved. Another issue is CAPA proliferation, where each deviation generates a separate CAPA without grouping related issues, overwhelming the quality system.
Conclusion
A mature CAPA system drives continuous improvement by ensuring that problems are not just fixed but prevented from recurring. Regulators view a strong CAPA system as evidence of a proactive, patient-focused quality culture.
